MedTrace Logo

Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

NCT00165256 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2025-12-29

No results posted yet for this study

Summary

The purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS) of the breast.

Conditions

  • Ductal Carcinoma in Situ of the Breast

Interventions

OTHER

Observation

Wide excision of DCIS and a minimum of 1cm histologically negative margin of breast tissue

Sponsors & Collaborators

Principal Investigators

  • Julia Wong, MD · Dana-Farber Cancer Institute

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-05-31
Primary Completion
2002-07-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00165256 on ClinicalTrials.gov